Replies to post #134211 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

There was advancement on 7 of 8..

Two new clinical pathologies..
Movement on PK in Europe
Movement on Rett Syndrome
Movement on MS
Movement on a3-71 and 1044

.. Alzheimer's is ridiculously slow..

Anyone diagnosed with dementia should have the option of taking A2-73.. what a cruel world..

[kevindenver]

The Alzheimer's Clinical Trials Consortium should definitely speed up development.

It's going to be interesting to see how biology, "big data", and cheap super computing will interact.

Who truly "owns" the result? Humanity wins, but will a company/companies and the government?
We are still basically capitalist, so I wonder.

[tredenwater2]

The same would apply for WSU for M/S given the lash up between WSU, Anavex and and Biogen.

Hi Talon

Nice post. I have been reading some regular chatter about Biogen being a tasty morsel takeover target for the likes of Roche, or Pfizer if Trumps tax plan pushes through. What if any effect would that have on an announcement of a partnership with AVXL. Possibly a delay due to a quiet period? My hope is that CM has not tied up our hands too much with the MTA.

Tred